Evidence map›Paper›PMID 42686760›Full record

ArticleNature communications2026

Innervated human cardiac muscle model reveals sympathetic drivers of KCNH2-associated arrhythmias.

Lennart Valentin Schneider, Michael Gani Setya, Guobin Bao, Daniel Härtter, Aditi Methi, Dennis Krüger, Marie Kristin Schreiber, Ole Jensen, Elisavet Kanari, Kea Aline Schmoll and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lennart Valentin Schneider *Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0009-0007-1634-697X
Michael Gani Setya *Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Guobin BaoInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Daniel HärtterInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0002-9582-6141
Aditi MethiGerman Center for Neurodegenerative Diseases, Göttingen, Germany.
Dennis KrügerGerman Center for Neurodegenerative Diseases, Göttingen, Germany.ORCID http://orcid.org/0000-0003-1950-9547
Marie Kristin SchreiberInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0003-2965-1491
Ole JensenDepartment of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0001-9903-4769
Elisavet KanariInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Kea Aline SchmollInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Narasimha Swamy TeluguMax Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Pluripotent Stem Cells, Berlin, Germany.
Sadman SakibGerman Center for Neurodegenerative Diseases, Göttingen, Germany.
Eun Seo KimInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0009-0008-7306-3009
Aminath Luveysa FahudInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0003-0613-4344
Maham NovinInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Aylin SeedorfInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Sebastian DieckeMax Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Pluripotent Stem Cells, Berlin, Germany.ORCID http://orcid.org/0000-0002-5219-5992
André FischerMBExC (Multi-Scale Bioimaging Excellence Cluster), Göttingen, Germany.
Norman Y LiawInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0001-7804-8133
Wolfram-Hubertus ZimmermannInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany. w.zimmermann@med.uni-goettingen.de.ORCID http://orcid.org/0000-0003-1190-4040
Maria-Patapia ZafeiriouInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany. patapia.zafeiriou@med.uni-goettingen.de.ORCID http://orcid.org/0000-0003-4604-4175

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 496553893
6 · The paper itself

Abstract

Cardiac autonomic neurons regulate contractility. Autonomic nervous system dysregulation can cause sympathetic overdrive, leading to heart failure, and fatal arrhythmias. Here, we introduce innervated engineered human myocardium (iEHM), a model of neuro-cardiac junctions, constructed by fusing sympathetic neuronal organoids (SNO) and engineered human myocardium (EHM). Projections of sympathetic neurons formed presynaptic terminals in close proximity to cardiomyocytes and to the extensive vascular network co-developing in iEHM. Contractile responses to optogenetic stimulation of the accordingly engineered neuronal component demonstrated functional neuro-cardiac junctions. Modeling long-QT 2 in iEHM revealed sympathetic neuron hyperactivity and after depolarizations, underscoring a central role for sympathetic drive in KCNH2-associated arrhythmias. β-adrenoreceptor blockade was insufficient to rescue the pro-arrhythmic phenotype, while mexiletine targeting both neurons and cardiomyocytes, proved to be more effective. Collectively, our data establishes iEHM as a New Approach Methodology that provides a human-relevant, physiologically integrated model for mechanistic investigations and pharmacological testing.

Indexed as

Arrhythmias, CardiacERG1 Potassium ChannelHeartMyocardiumSympathetic Nervous SystemHumansMyocytes, CardiacNeuronsOptogeneticsERG1 Potassium ChannelKCNH2 protein, human

Identifiers

PMID42686760
PMCPMC13538559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.